SPX3,585.62-54.85 -1.51%
DIA287.30-4.91 -1.68%
IXIC10,575.62-161.89 -1.51%

Argus Research Maintains Buy on Moderna, Lowers Price Target to $150

Argus Research analyst Jasper Hellweg maintains Moderna (NASDAQ:MRNA) with a Buy and lowers the price target from $180 to $150.

Benzinga · 09/14/2022 08:44
Argus Research analyst Jasper Hellweg maintains Moderna (NASDAQ:MRNA) with a Buy and lowers the price target from $180 to $150.